More support for plan to globalize EU funds

MRC head says allowing non-EU scientists to apply for EU funding could ultimately benefit Europe

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
The chief executive of Britain's Medical Research Council has lent his support to a proposal to allow some researchers from the US and elsewhere to apply for funding from European Union coffers, arguing Europe could benefit from the establishment of reciprocal funding arrangements. Colin Blakemore, whose term at the helm of the UK agency ends in September, told The Scientist he welcomed recent debate on the issue, which was sparked in late April at a meeting of the standing committee of the European Medical Research Councils (EMRC) in Stockholm.The driving force behind the debate was Liselotte Højgaard, the Danish chair of the standing committee. She told The Scientist that the meeting had been positive. "There was a big interest in talking about it for the sake of fair play, and because science is global," she said. At the end of the meeting, members agreed to raise the issue with their local authorities and return with an opinion at another EMRC meeting in October.Blakemore wasn't at the meeting, but said he thought it unlikely that European Commission (EC) funding could be opened up internationally on a purely competitive basis. "But I think that there would be some support for reciprocal funding arrangements between the EC and other countries, including the US, with restrictions on eligibility similar to those for NIH funding of non-Americans," he said in an Email.For example, he said, funding might be limited to researchers who can offer expertise or resources that are not available within Europe, or where there is a strategic need of particular importance to European citizens. In clinical trials, Europe might benefit from gaining access to unusual patient groups or specialized diagnostics, Blakemore suggested. "Similar arguments might also apply to topics of very high strategic priority, such as more rapid development of influenza vaccines," he said.Many of Europe's top scientists benefit from NIH funding, Blakemore said, and papers co-published by US and EU scientists tend to be most highly cited. "It is timely, then, for the EMRC to have initiated a discussion about the opportunities for Europe from making some forms of European funding available to researchers elsewhere."Still, Blakemore said he expected the idea to meet opposition. "Despite the strength of the case, I expect that there will be resistance to opening up the new European Research Council to international applications because its starting budget is so very small compared with the breadth of its remit in Europe." The ERC has 7.5 billion Euros ($9.9 billion US) to support it through its first seven years, although campaigning to increase that budget has already begun. Håkan Bilig, secretary general, medicine at the Swedish Research Council, was at the meeting in Stockholm. He said the EMRC had an important part to play in raising difficult issues such as this one, even though it has no power to change EU funding arrangements itself. "I think the important thing is that we have to start discussing this because for many [countries] it is a new concept," he told The Scientist. "If we hadn't done this it might not have been started. We may not be able to end the discussions but we can be part of getting it going."Stephen Pincock mail@the-scientist.comLinks within this articleS. Pincock, " Some support for EU funding for US researchers," The Scientist, April 23, 2007. http://www.the-scientist.com/news/display/53113/S. Pincock, "MRC head to step down," The Scientist, March 8, 2007. http://www.the-scientist.com/news/display/52932/S. Pincock, "Could US scientists get EU funding?" The Scientist, April 19, 2007. http://www.the-scientist.com/news/home/53079European Medical Research Councils http://www.esf.org/research-areas/medical-sciences/about/standing-committee.htmlLiselotte Højgaard http://pet.rh.dk/Liselotte/S. Pincock, "ERC flooded by first round of grants," The Scientist, May 1, 2007. http://www.the-scientist.com/news/display/53173/Håkan Billig http://www.vr.se
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Stephen Pincock

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio